Cargando…
Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway
Astragalus propinquus Schischkin and Salvia miltiorrhiza Bunge (AS) have been clinically used as adjunctive drugs in the treatment of myocardial ischemia (MI). However, the effect and mechanism of AS on MI have yet to be fully recognized. Here, we explored the cardioprotective effect of their combin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868545/ https://www.ncbi.nlm.nih.gov/pubmed/36699092 http://dx.doi.org/10.3389/fphar.2022.1103557 |
_version_ | 1784876561794596864 |
---|---|
author | Zhang, Mu-Xin Huang, Xue-Ying Song, Yu Xu, Wan-Li Li, Yun-Lun Li, Chao |
author_facet | Zhang, Mu-Xin Huang, Xue-Ying Song, Yu Xu, Wan-Li Li, Yun-Lun Li, Chao |
author_sort | Zhang, Mu-Xin |
collection | PubMed |
description | Astragalus propinquus Schischkin and Salvia miltiorrhiza Bunge (AS) have been clinically used as adjunctive drugs in the treatment of myocardial ischemia (MI). However, the effect and mechanism of AS on MI have yet to be fully recognized. Here, we explored the cardioprotective effect of their combined use, and the mechanism of promoting angiogenesis through pericyte recruitment. Our data revealed that AS reduced MI and protects cardiac function. AS-treated MI mice exhibited reduced ST-segment displacement and repolarization time, increased ejection fraction, and less BNP and NT-proBNP expression. Pathological studies showed that, AS reduced the area of infarcted myocardium and slowed down the progress of cardiac remodelling and fibrosis. In addition, AS increased the content of platelet-derived growth factor receptors β (PDGFR-β), platelet endothelial cell adhesion molecule-1 (CD31) and angiogenesis-related proteins including vascular endothelial cadherin (VE-cadherin), Vascular Endothelial Growth Factor (VEGF) and transforming growth factor β (TGF-β). Moreover, these botanical drugs upregulated the expression of Angiopoietin-1 (Ang-1), phosphorylated angiopoietin-1 receptor (p-Tie-2), focal adhesion kinase (FAK) and growth factor receptor bound protein 7 (GRB7), indicating that the cardioprotection-related angiogenesis effect was related to pericyte recruitment, which may be through Ang-1/Tie-2/FAK pathway. In summary, AS can treat MI by protecting cardiac function, attenuating cardiac pathological changes, and hindering the progression of heart failure, which is related to angiogenesis after pericyte recruitment. Therefore, AS at a certain dose can be a promising treatment for MI with broad application prospects. |
format | Online Article Text |
id | pubmed-9868545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98685452023-01-24 Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway Zhang, Mu-Xin Huang, Xue-Ying Song, Yu Xu, Wan-Li Li, Yun-Lun Li, Chao Front Pharmacol Pharmacology Astragalus propinquus Schischkin and Salvia miltiorrhiza Bunge (AS) have been clinically used as adjunctive drugs in the treatment of myocardial ischemia (MI). However, the effect and mechanism of AS on MI have yet to be fully recognized. Here, we explored the cardioprotective effect of their combined use, and the mechanism of promoting angiogenesis through pericyte recruitment. Our data revealed that AS reduced MI and protects cardiac function. AS-treated MI mice exhibited reduced ST-segment displacement and repolarization time, increased ejection fraction, and less BNP and NT-proBNP expression. Pathological studies showed that, AS reduced the area of infarcted myocardium and slowed down the progress of cardiac remodelling and fibrosis. In addition, AS increased the content of platelet-derived growth factor receptors β (PDGFR-β), platelet endothelial cell adhesion molecule-1 (CD31) and angiogenesis-related proteins including vascular endothelial cadherin (VE-cadherin), Vascular Endothelial Growth Factor (VEGF) and transforming growth factor β (TGF-β). Moreover, these botanical drugs upregulated the expression of Angiopoietin-1 (Ang-1), phosphorylated angiopoietin-1 receptor (p-Tie-2), focal adhesion kinase (FAK) and growth factor receptor bound protein 7 (GRB7), indicating that the cardioprotection-related angiogenesis effect was related to pericyte recruitment, which may be through Ang-1/Tie-2/FAK pathway. In summary, AS can treat MI by protecting cardiac function, attenuating cardiac pathological changes, and hindering the progression of heart failure, which is related to angiogenesis after pericyte recruitment. Therefore, AS at a certain dose can be a promising treatment for MI with broad application prospects. Frontiers Media S.A. 2023-01-09 /pmc/articles/PMC9868545/ /pubmed/36699092 http://dx.doi.org/10.3389/fphar.2022.1103557 Text en Copyright © 2023 Zhang, Huang, Song, Xu, Li and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhang, Mu-Xin Huang, Xue-Ying Song, Yu Xu, Wan-Li Li, Yun-Lun Li, Chao Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway |
title |
Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway |
title_full |
Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway |
title_fullStr |
Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway |
title_full_unstemmed |
Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway |
title_short |
Astragalus propinquus schischkin and Salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via Ang-1/Tie-2/FAK pathway |
title_sort | astragalus propinquus schischkin and salvia miltiorrhiza bunge promote angiogenesis to treat myocardial ischemia via ang-1/tie-2/fak pathway |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868545/ https://www.ncbi.nlm.nih.gov/pubmed/36699092 http://dx.doi.org/10.3389/fphar.2022.1103557 |
work_keys_str_mv | AT zhangmuxin astragaluspropinquusschischkinandsalviamiltiorrhizabungepromoteangiogenesistotreatmyocardialischemiaviaang1tie2fakpathway AT huangxueying astragaluspropinquusschischkinandsalviamiltiorrhizabungepromoteangiogenesistotreatmyocardialischemiaviaang1tie2fakpathway AT songyu astragaluspropinquusschischkinandsalviamiltiorrhizabungepromoteangiogenesistotreatmyocardialischemiaviaang1tie2fakpathway AT xuwanli astragaluspropinquusschischkinandsalviamiltiorrhizabungepromoteangiogenesistotreatmyocardialischemiaviaang1tie2fakpathway AT liyunlun astragaluspropinquusschischkinandsalviamiltiorrhizabungepromoteangiogenesistotreatmyocardialischemiaviaang1tie2fakpathway AT lichao astragaluspropinquusschischkinandsalviamiltiorrhizabungepromoteangiogenesistotreatmyocardialischemiaviaang1tie2fakpathway |